Episode Details
Back to Episodes
U.S. Funds Gavi’s Mercury Vaccine Shift | Salt Lake City News
Description
The Trump administration just unlocked $600 million for Gavi, the global vaccine alliance — but with a major condition: ditch mercury from all vaccines. After years of U.S. pressure, Gavi agrees to replace mercury-containing shots for key diseases like meningitis and pneumonia with safer, mercury-free versions — and even add broader disease protection. While the funding kicks in immediately, full rollout takes time as manufacturers scale up, countries adopt new vaccines, and Gavi’s board gives final approval. Plus, the U.S. is rejoining Gavi’s board to oversee progress. Beyond mercury, Gavi also commits to ending routine COVID-19 vaccine promotion and restructuring partnerships — a bold move framing this as a win for global health and science.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/08cfcee66b5bfb32